Similarly, in a BCRP (−/−) mouse model with orthotopically transplanted BC tumor cells, co-treatment with topotecan and the BCRP inhibitor Ko143 significantly increased survival compared to topotecan monotheraphy [32]. This evidence concerns the gene ABCG2 and breast cancer.